The Australasian Lymphology Association (ALA) is the peak professional body for education, research and management of lymphoedema in Australia and New Zealand. The ALA represents over 750 members, consisting of medical professionals, researchers and educators.
The ALA has as its primary objectives, to raise awareness of lymphoedema, provide high quality education and resources, and encourage and support lymphoedema research.
The ALA takes a strong position on advocating for improved services and support for lymphoedema treatment. In addition, a current key focus is to lobby for improved and equitable access to compression garment subsidies.
The ALA provides accreditation for lymphoedema practitioners via the ALA Accredited Lymphoedema Practitioner Program (ALPP). The ALPP is a robust self-regulated scheme for lymphoedema practitioners who have acquired an appropriate level of lymphoedema education and professional competence, demonstrate currency of practice and participate in continuing professional development. ALA Accredited Lymphoedema Practitioners must adhere to a Code of Professional Conduct and Ethical Practice, demonstrate recency of practice and comply with a range of mandatory declarations.